AU2001251467A1 - Methods of making models, methods of using models of murg, compounds that bind, inhibit or stimulate muret proteins, and therapeutic compositions thereof - Google Patents

Methods of making models, methods of using models of murg, compounds that bind, inhibit or stimulate muret proteins, and therapeutic compositions thereof

Info

Publication number
AU2001251467A1
AU2001251467A1 AU2001251467A AU5146701A AU2001251467A1 AU 2001251467 A1 AU2001251467 A1 AU 2001251467A1 AU 2001251467 A AU2001251467 A AU 2001251467A AU 5146701 A AU5146701 A AU 5146701A AU 2001251467 A1 AU2001251467 A1 AU 2001251467A1
Authority
AU
Australia
Prior art keywords
methods
models
muret
murg
stimulate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001251467A
Inventor
Sha Ha
Suzanne Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Princeton University
Original Assignee
Princeton University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Princeton University filed Critical Princeton University
Publication of AU2001251467A1 publication Critical patent/AU2001251467A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2001251467A 2000-05-17 2001-04-09 Methods of making models, methods of using models of murg, compounds that bind, inhibit or stimulate muret proteins, and therapeutic compositions thereof Abandoned AU2001251467A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20493000P 2000-05-17 2000-05-17
US60204930 2000-05-17
PCT/US2001/011500 WO2001090301A2 (en) 2000-05-17 2001-04-09 Crystallizing murg protein, methods of making and using models thereof for inhibition and stimulation via compounds

Publications (1)

Publication Number Publication Date
AU2001251467A1 true AU2001251467A1 (en) 2001-12-03

Family

ID=22760066

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001251467A Abandoned AU2001251467A1 (en) 2000-05-17 2001-04-09 Methods of making models, methods of using models of murg, compounds that bind, inhibit or stimulate muret proteins, and therapeutic compositions thereof

Country Status (2)

Country Link
AU (1) AU2001251467A1 (en)
WO (1) WO2001090301A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911545B2 (en) 2001-12-19 2005-06-28 Hoffman-La Roche Inc. Crystals of glucokinase and methods of growing them
EP1554394B1 (en) 2002-10-16 2009-12-16 Isis Innovation Limited Screening methods using a structural model of FIH
WO2012068053A1 (en) * 2010-11-16 2012-05-24 Vertex Pharmaceuticals Incorporated Crystal structure of pseudomonas aeruginosa murg enzyme

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068191A (en) * 1989-08-31 1991-11-26 The Biomembrane Institute Purified histo-blood group a glycosyltransferase and antibodies thereto
JP2002501931A (en) * 1998-02-02 2002-01-22 プリンストン ユニバーシティ MurG substrate analog, method for producing the same and assay using the same

Also Published As

Publication number Publication date
WO2001090301A2 (en) 2001-11-29
WO2001090301A3 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
AU2002230831A1 (en) Compositions of human proteins and method of use thereof
TWI315988B (en) Chemically modified novel erythropoietin stimulating protein compositions and methods
AU2001241474A1 (en) Biosensor compositions and methods of use
AU2001233081A1 (en) Composition for treatment of stress
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2001234782A1 (en) Compositions and methods for promoting healthy joints
AU2001294556A1 (en) Methods and compositions for the construction and use of fusion libraries
AU1189201A (en) Therapeutic compositions including protein kinase c inhibitors
AU2002362589A1 (en) Basecoat composition and application methods therewith
AU2002251999A1 (en) Methods and compositions for the construction and use of fusion libraries using computational protein design methods
EP1435996A4 (en) Compositions comprising mixtures of therapeutic proteins and methods of producing the same
AU2001251467A1 (en) Methods of making models, methods of using models of murg, compounds that bind, inhibit or stimulate muret proteins, and therapeutic compositions thereof
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2002364911A1 (en) Dmt-tic di- and tri-peptidic derivatives and related compositions and methods of use
AU2002242111A1 (en) Frozen biocidal compositions and methods of use thereof
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2001297575A1 (en) 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
AU2002354363A1 (en) Method of activating protein
AU2001271281A1 (en) Novel compositions for the expression of the human peptide histidine transporter1 and methods of use thereof
AU2002355432A1 (en) Kavalactone compositions and methods of use
AU2001278204A1 (en) Methods of selecting and cloning animals
AU2002319620A1 (en) Functional site profiles for proteins and methods of making and using the same
AU2001297794A1 (en) Methods and compositions of human proteins and uses thereof.
AU2001253469A1 (en) Compositions and methods for stabilizing modified tissue